1.Mechanism of Yishen Huoxue Tongqiao Formula in Improving Unilateral Vestibular Labyrinth Destruction by Regulating Metabolism-neuroplasticity
Yu TIAN ; Hui LENG ; Rupeng QU ; Xianglong HAO ; Aiping WANG ; Lei SHI ; Zhongyuan QU ; Ye DONG ; Xiande MA ; Yangling HUANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(5):54-64
ObjectiveThis study aims to explore the mechanism by which Yishen Huoxue Tongqiao Formula improves metabolism-neuroplasticity and treats unilateral vestibular labyrinth destruction by regulating the metabolic balance of glutamate (Glu)/γ-aminobutyric acid (GABA). Methods48 Sprague-Dawley (SD) adult rats were randomly divided into the sham operation group, model group, Yishen Huoxue Tongqiao Formula groups with low, medium, and high doses (9.20, 18.39, 36.78 g·kg-1), and betahistine group (1.62 mg·kg-1). A unilateral vestibular labyrinth destruction (vestibular dysfunction) model was established by intratympanic injection of chloroform into the right ear, while the control group received intratympanic injection of normal saline. Drugs were administered once daily for seven consecutive days. During the period, behavioral tests were performed to evaluate the behaviors of rats after unilateral vestibular labyrinth destruction. Hematoxylin-eosin (HE) staining and Nissl staining were used to observe the neuronal morphology in the medial vestibular nucleus. Golgi staining was employed to assess the number of dendritic spines of neurons in the medial vestibular nucleus. Ultra-performance liquid chromatography-tandem mass spectrometry (LC-ESI-MS/MS) was utilized to detect Glu/GABA. Immunofluorescence and immunohistochemistry were used to detect the expressions of neuronal nuclei (NeuN), growth-associated protein 43 (GAP-43), and glial fibrillary acidic protein (GFAP). Western blot and real-time fluorescent quantitative polymerase chain reaction (Real-time PCR) were applied to determine the expressions of glutamate-immunoreactive (Glu-IR), GABA, GFAP, postsynaptic density protein 95 (PSD-95), and GAP-43. ResultsCompared with the sham operation group, the model group presented with head deviation, balance disorder, increased tail suspension score, nuclear consolidation of medial vestibular nerve neurons, and decreased Nissl bodies (P<0.01). The number of dendritic spines in neurons and NeuN-positive cells decreased. The content of Glu decreased. The content of GABA increased (Glu/GABA decreased). The expression of GAP-43 was down-regulated, and GFAP was up-regulated (P<0.05, P<0.01). The expressions of Glu-IR, PSD-95, and GAP-43 proteins, as well as Glu-IR mRNA decreased, while the expressions of GABA and GFAP proteins and mRNA increased (P<0.05, P<0.01). Compared with those in the model group, the head deviation, imbalanced behavior, and tail suspension scores in each treatment group decreased, with alleviated neuronal injury and recovered Nissl bodies (P<0.01). The number of dendritic spines of neurons increased, and the number of NeuN-positive cells rebounded. The content of Glu increased, and the content of GABA decreased (Glu/GABA increased). GFAP was down-regulated, and GAP-43 was up-regulated (P<0.05, P<0.01). The expressions of Glu-IR, PMD-95, and GAP-43 proteins, as well as Glu-IR mRNA increased, while the expressions of GABA and GFAP proteins and mRNA decreased. The effect was more significant in the high-dose group (P<0.01). ConclusionThe Yishen Huoxue Tongqiao Formula can alleviate vestibular dysfunction, and its mechanism may be associated with regulating the metabolic balance of Glu/GABA, mitigating neural damage, improving synaptic plasticity (promoting GAP-43 expression and inhibiting GFAP expression), and facilitating vestibular compensation.
2.Diagnosis and treatment of colorectal liver metastases: Chinese expert consensus-based multidisciplinary team (2024 edition).
Wen ZHANG ; Xinyu BI ; Yongkun SUN ; Yuan TANG ; Haizhen LU ; Jun JIANG ; Haitao ZHOU ; Yue HAN ; Min YANG ; Xiao CHEN ; Zhen HUANG ; Weihua LI ; Zhiyu LI ; Yufei LU ; Kun WANG ; Xiaobo YANG ; Jianguo ZHOU ; Wenyu ZHANG ; Muxing LI ; Yefan ZHANG ; Jianjun ZHAO ; Aiping ZHOU ; Jianqiang CAI
Chinese Medical Journal 2025;138(15):1765-1768
3.Exploration and practice of teaching reform in Synthetic Biology.
Bo ZHANG ; Lianggang HUANG ; Aiping PANG ; Zheyan WU ; Junping ZHOU ; Xue CAI ; Lijuan WANG ; Kun NIU ; Liqun JIN ; Zhiqiang LIU ; Yuguo ZHENG
Chinese Journal of Biotechnology 2025;41(8):3311-3317
Synthetic biology is a crucial tool for the development of the bio-industry and bio-economy, representing a significant aspect of new quality productive forces. As a core course for graduate students in bioengineering, Synthetic Biology plays a vital role in ensuring the supply of essential talents for the development of the bio-industry in the new era. To better serve regional economic development and provide high-level talents for China's progress in the bio-industry, we analyzed typical issues encountered in the past teaching activities, set up a multi-disciplinary teaching team, optimized the course contents, adjusted the teaching mode, and mobilized students' learning interest. With the application of scientific research project as the starting point, we guided students to think and discuss deeply through the simulation of application writing and project defense, which improved students' critical thinking and innovative thinking. With industrialization as a focus, we explored a new training model combining production, education, and research through the joint practice base of the university and enterprises introduced typical cases of biomanufacturing to encourage students to engage in scientific research. The teaching reform significantly enhances the comprehensive abilities and national sentiments of graduate students. This paper hopes to serve as a reference for colleagues engaged in teaching in this field.
Synthetic Biology/education*
;
Teaching
;
China
;
Humans
4.Inhaled non-viral delivery systems for RNA therapeutics.
Cheng HUANG ; Hongjian LI ; Xing DUAN ; Peidong ZHANG ; Shaolong QI ; Jianshi DU ; Xiangrong SONG ; Aiping TONG ; Guocan YU
Acta Pharmaceutica Sinica B 2025;15(5):2402-2430
RNA-based gene therapy has been widely used for various diseases, and extensive studies have proved that suitable delivery routes greatly help the development of RNA therapeutics. Identifying a safe and effective delivery system is key to realizing RNA therapeutics' clinical translation. Inhalation is a non-invasive pulmonary delivery modality that can enhance the retention of therapeutic agents in the lungs with negligible toxicity, thereby improving patient compliance. Inhaled RNA therapeutics are increasingly becoming an area of focus for researchers; however, only several clinical trials have explored inhaled delivery of RNA for pulmonary diseases. This review presents an overview of recent advances in inhaled delivery systems for RNA therapeutics, including viral and nonviral systems, highlighting state of the art regarding inhalation in the messenger RNA (mRNA) field. We also summarize the applications of mRNA inhalants in infectious and other lung diseases. Simultaneously, the research progresses on small interfering RNAs (siRNAs), antisense oligonucleotides (ASOs), and different types of RNA are also discussed to provide new strategies for developing RNA inhalation therapy. Finally, we clarify the challenges inhaled RNA-based therapeutics face before their widespread adoption and provide insights to help advance this exciting field to the bedside.
5.The chordata olfactory receptor database.
Wei HAN ; Siyu BAO ; Jintao LIU ; Yiran WU ; Liting ZENG ; Tao ZHANG ; Ningmeng CHEN ; Kai YAO ; Shunguo FAN ; Aiping HUANG ; Yuanyuan FENG ; Guiquan ZHANG ; Ruiyi ZHANG ; Hongjin ZHU ; Tian HUA ; Zhijie LIU ; Lina CAO ; Xingxu HUANG ; Suwen ZHAO
Protein & Cell 2025;16(4):286-295
6.Immune-Enhancing Treatment among Acute Necrotizing Pancreatitis Patients with Metabolic Abnormalities: A Post Hoc Analysis of a Randomized Clinical Trial
Xiaofei HUANG ; Wenjian MAO ; Xingxing HU ; Fengxia QIN ; Hui ZHAO ; Aiping ZHANG ; Xinyu WANG ; Christian STOPPE ; Dandan ZHOU ; Lu KE ; Haibin NI ; Chinese Acute Pancreatitis Clinical Trials Group (CAPCTG)
Gut and Liver 2024;18(5):906-914
Background/Aims:
Metabolic syndrome is common in patients with acute pancreatitis and its components have been reported to be associated with infectious complications. In this post hoc analysis, we aimed to evaluate whether metabolic abnormalities impact the effect of immuneenhancing thymosin alpha-1 (Tα1) therapy in acute necrotizing pancreatitis (ANP) patients.
Methods:
All data were obtained from the database for a multicenter randomized clinical trial that evaluated the efficacy of Tα1 in ANP patients. Patients who discontinued the Tα1 treatment prematurely were excluded. The primary outcome was 90-day infected pancreatic necrosis (IPN) after randomization. Three post hoc subgroups were defined based on the presence of hyperglycemia, hypertriglyceridemia, or both at the time of randomization. In each subgroup, the correlation between Tα1 and 90-day IPN was assessed using the Cox proportional-hazards regression model. Multivariable propensity-score methods were used to control potential bias.
Results:
Overall, 502 participants were included in this post hoc analysis (248 received Tα1 treatment and 254 received matching placebo treatment). Among them, 271 (54.0%) had hyperglycemia, 371 (73.9%) had hypertriglyceridemia and 229 (45.6%) had both. Tα1 therapy was associated with reduced incidence of IPN among patients with hyperglycemia (18.8% vs 29.7%: hazard ratio, 0.80; 95% confidence interval, 0.37 to 0.97; p=0.03), but not in the other subgroups. Additional multivariate regression models using three propensity-score methods yielded similar results.
Conclusions
Among ANP patients with hyperglycemia, immune-enhancing Tα1 treatment was associated with a reduced risk of IPN (ClinicalTrials.gov, Registry number: NCT02473406).
7.Discussion on Internal Control Strategies for Government Special Bond Procurement of Medical Equipment
Chinese Health Economics 2024;43(11):87-90
With the widespread application of government special bonds in the financing of public hospitals in China,an in-depth analysis of the internal control strategies of this financing method in medical equipment procurement is of great significance for promoting the management of government special bonds and the sustainable and healthy development of the medical and health industry.It explores the five core elements of internal environment,risk assessment,control activities,information and communication,and internal supervision from the perspective of internal control.Research has found that in the process of using government special bonds to purchase medical equipment,there are multiple problems such as reduced efficiency in fund utilization,high usage costs,and high repayment pressure.Therefore,it proposes optimization strategies such as slowing down the issuance speed,formulating interest and principal repayment budgets,and conducting full life cycle procurement argumentation,in order to provide reference suggestions for improving the management efficiency of government special bonds and the internal control level of public hospitals.
8.Discussion on Internal Control Strategies for Government Special Bond Procurement of Medical Equipment
Chinese Health Economics 2024;43(11):87-90
With the widespread application of government special bonds in the financing of public hospitals in China,an in-depth analysis of the internal control strategies of this financing method in medical equipment procurement is of great significance for promoting the management of government special bonds and the sustainable and healthy development of the medical and health industry.It explores the five core elements of internal environment,risk assessment,control activities,information and communication,and internal supervision from the perspective of internal control.Research has found that in the process of using government special bonds to purchase medical equipment,there are multiple problems such as reduced efficiency in fund utilization,high usage costs,and high repayment pressure.Therefore,it proposes optimization strategies such as slowing down the issuance speed,formulating interest and principal repayment budgets,and conducting full life cycle procurement argumentation,in order to provide reference suggestions for improving the management efficiency of government special bonds and the internal control level of public hospitals.
9.Discussion on Internal Control Strategies for Government Special Bond Procurement of Medical Equipment
Chinese Health Economics 2024;43(11):87-90
With the widespread application of government special bonds in the financing of public hospitals in China,an in-depth analysis of the internal control strategies of this financing method in medical equipment procurement is of great significance for promoting the management of government special bonds and the sustainable and healthy development of the medical and health industry.It explores the five core elements of internal environment,risk assessment,control activities,information and communication,and internal supervision from the perspective of internal control.Research has found that in the process of using government special bonds to purchase medical equipment,there are multiple problems such as reduced efficiency in fund utilization,high usage costs,and high repayment pressure.Therefore,it proposes optimization strategies such as slowing down the issuance speed,formulating interest and principal repayment budgets,and conducting full life cycle procurement argumentation,in order to provide reference suggestions for improving the management efficiency of government special bonds and the internal control level of public hospitals.
10.Discussion on Internal Control Strategies for Government Special Bond Procurement of Medical Equipment
Chinese Health Economics 2024;43(11):87-90
With the widespread application of government special bonds in the financing of public hospitals in China,an in-depth analysis of the internal control strategies of this financing method in medical equipment procurement is of great significance for promoting the management of government special bonds and the sustainable and healthy development of the medical and health industry.It explores the five core elements of internal environment,risk assessment,control activities,information and communication,and internal supervision from the perspective of internal control.Research has found that in the process of using government special bonds to purchase medical equipment,there are multiple problems such as reduced efficiency in fund utilization,high usage costs,and high repayment pressure.Therefore,it proposes optimization strategies such as slowing down the issuance speed,formulating interest and principal repayment budgets,and conducting full life cycle procurement argumentation,in order to provide reference suggestions for improving the management efficiency of government special bonds and the internal control level of public hospitals.

Result Analysis
Print
Save
E-mail